Chronic myeloid leukaemia: open trials in Russia

• NCT04925479

  Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia

  Trial Treatment · Phase 1/2 · Novartis Pharmaceuticals

  Moscow · Saint Petersburg

  Registry updated 2026-09-25

• NCT06423911

  Study of Olverembatinib (HQP1351) in Patients With CML-CP

  Trial Treatment · Phase 3 · Ascentage Pharma Group Inc.

  Moscow · Saint Petersburg · Saint Petersburg · Saint Petersburg

  Registry updated 2026-09-15

• NCT03459534

  A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs

  Trial Treatment · Phase 3 · Il-Yang Pharm. Co., Ltd.

  Territorial State Budgetary Institution, Barnaul · Federal State Budgetary Institution of Science, Kirov · Federal State Budgetary Institution, Moscow · Hematology Centre based on City Clin. Hosp. n.a. S.P. Botkin, Moscow · Federal State Budgetary Institution, Saint Petersburg

  Registry updated 2026-09-03

• NCT04877522

  Asciminib Roll-over Study

  Trial Treatment · Phase 4 · Novartis Pharmaceuticals

  Moscow · Saint Petersburg

  Registry updated 2026-07-06

• NCT07238712

  Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor

  Trial Treatment · Phase 2 · St. Petersburg State Pavlov Medical University

  Pavlov University, Saint Petersburg

  Registry updated 2025-11-20

• NCT06532084

  Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen

  Trial Treatment · Phase 2 · St. Petersburg State Pavlov Medical University

  RM Gorbacheva Research Institute, Saint Petersburg

  Registry updated 2024-08-01

• NCT06508099

  Vitamin A and D Supplementation in Allogeneic HCT

  Trial Treatment · Phase 2 · St. Petersburg State Pavlov Medical University

  RM Gorbacheva Research Institute, Saint Petersburg

  Registry updated 2024-07-31

All Chronic myeloid leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error